Efficacy and safety of neoadjuvant chemotherapy with toripalimab in locally advanced nasopharyngeal…

Genomic alterations associated with response to neoadjuvant toripalimab plus chemotherapy in locally advanced esophageal squamous cell carcinoma.
Xiao Yang, Shuo Sun, He Xiao +8
Journal of gastrointestinal oncology31 Aug 2026Peer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMC
Toripalimab combined with chemotherapy in the treatment of primary tracheal squamous cell carcinoma: a phase II proof-of-concept study
Translational Lung Cancer Research31 Aug 2026Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
First-line toripalimab in combination with platinum-doublet chemotherapy for advanced B3 thymoma and thymic carcinoma: an open-label prospective phase Ⅱ trial.
K Zhu, H Zhu, H Shi +10
ESMO open9 Oct 2026Peer-reviewedCC BY-NC-NDFull textNeurologyEurope PMC
Cost-effectiveness of disitamab vedotin plus toripalimab versus chemotherapy alone as first-line treatment for HER2-overexpressing advanced urothelial carcinoma: a cost-effectiveness analysis from the Chinese healthcare system perspective
Yang Liu, Lin Qiao, Xiaofei Li +6
Frontiers in Oncology4 Nov 2026Peer-reviewedCC BY 4.0OncologyFrontiersCrossref
Osteoclast-like giant cell variant of bladder urothelial carcinoma with poor response to neoadjuvant chemotherapy managed by robot-assisted radical cystoprostatectomy: A case report
Abdelhakim Oukouhou, Mohamed Tetou, Saad Assila +3
Urology Case Reports12 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textOncologyPMCEurope PMC

Cite

BibTeX

@article{cao2026efficacy,
  title = {{Efficacy and safety of neoadjuvant chemotherapy with toripalimab in locally advanced nasopharyngeal carcinoma: a phase II trial and biological correlate analysis}},
  author = {Caineng Cao and Yulu Shen and Mengyun Qiang and Shuang Huang and Rong Zhang and Yi Zhou and Meiyan Rao and Xiaochao Zhao and Jianpeng Zhang and Yonghong Hua and Feng Jiang and Xiaozhong Chen},
  journal = {eClinicalMedicine},
  year = {2026},
  month = nov,
  doi = {10.1016/j.eclinm.2026.104316},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S2589537026005699},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - Efficacy and safety of neoadjuvant chemotherapy with toripalimab in locally advanced nasopharyngeal carcinoma: a phase II trial and biological correlate analysis
AU  - Caineng Cao
AU  - Yulu Shen
AU  - Mengyun Qiang
AU  - Shuang Huang
AU  - Rong Zhang
AU  - Yi Zhou
AU  - Meiyan Rao
AU  - Xiaochao Zhao
AU  - Jianpeng Zhang
AU  - Yonghong Hua
AU  - Feng Jiang
AU  - Xiaozhong Chen
PY  - 2026
DA  - 2026/11/01
JO  - eClinicalMedicine
DO  - 10.1016/j.eclinm.2026.104316
UR  - https://linkinghub.elsevier.com/retrieve/pii/S2589537026005699
SN  - 2589-5370
ER  -

Related

Cite